Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. Juli 2022 14:36 ET | Quelle: STRATEGIC MARKET RESEARCH LLP

Recombinant DNA Technology is expected to reach a valuation of USD 1.378 trillion by 2030.

New York, United States, July 07, 2022 (GLOBE NEWSWIRE) -- The factors accelerating the market’s growth are high investments in Research and Development, the quick adoption of the genetically...
14. März 2018 09:45 ET | Quelle: Rich Pharmaceuticals

Rich Pharmaceuticals' Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma

BEVERLY HILLS, CA , March 14, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology,...
25. April 2013 08:00 ET | Quelle: ClearPoint Neuro, Inc.

MRI Interventions' ClearPoint(R) System Helps Advance Brain Cancer Clinical Trial of Investigational Gene Therapy Drug Toca 511, Demonstrates Benefits of MRI-Guided Drug Delivery

IRVINE, Calif., April 25, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Intervention System is advancing the minimally-invasive...